Synthesis and biological activity of 5'-aminobenzoxazinorifamycin derivatives. 1992

T Yamane, and T Hashizume, and K Yamashita, and K Hosoe, and T Hidaka, and K Watanabe, and H Kawaharada, and S Kudoh
Biochemical Research Laboratories, Kaneka Corporation, Hyogo, Japan.

Benzoxazinorifamycin reacted with various secondary amines to yield various 5'-substituted aminobenzoxazinorifamycin derivatives. The derivatives exhibited potent activities against gram-positive bacteria and mycobacteria. The antimicrobial activities of these compounds against Mycobacterium tuberculosis and Mycobacterium intracellulare were superior to those of rifampicin. Some of these compounds showed good plasma levels after oral administration in rats.

UI MeSH Term Description Entries
D008297 Male Males
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000904 Antibiotics, Antitubercular Substances obtained from various species of microorganisms that are, alone or in combination with other agents, of use in treating various forms of tuberculosis; most of these agents are merely bacteriostatic, induce resistance in the organisms, and may be toxic. Antitubercular Antibiotics
D012294 Rifamycins A group of ANTI-BACTERIAL AGENTS characterized by a chromophoric naphthohydroquinone group spanned by an aliphatic bridge not previously found in other known ANTI-BACTERIAL AGENTS. They have been isolated from fermentation broths of Streptomyces mediterranei. Rifamycin,Rifomycin,Rifomycins
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

T Yamane, and T Hashizume, and K Yamashita, and K Hosoe, and T Hidaka, and K Watanabe, and H Kawaharada, and S Kudoh
April 2007, Bioorganic & medicinal chemistry letters,
T Yamane, and T Hashizume, and K Yamashita, and K Hosoe, and T Hidaka, and K Watanabe, and H Kawaharada, and S Kudoh
January 2015, Bioorganic & medicinal chemistry letters,
T Yamane, and T Hashizume, and K Yamashita, and K Hosoe, and T Hidaka, and K Watanabe, and H Kawaharada, and S Kudoh
January 2008, Bioorganicheskaia khimiia,
T Yamane, and T Hashizume, and K Yamashita, and K Hosoe, and T Hidaka, and K Watanabe, and H Kawaharada, and S Kudoh
February 2016, Molecular diversity,
T Yamane, and T Hashizume, and K Yamashita, and K Hosoe, and T Hidaka, and K Watanabe, and H Kawaharada, and S Kudoh
November 2003, Farmaco (Societa chimica italiana : 1989),
T Yamane, and T Hashizume, and K Yamashita, and K Hosoe, and T Hidaka, and K Watanabe, and H Kawaharada, and S Kudoh
January 1989, Yao xue xue bao = Acta pharmaceutica Sinica,
T Yamane, and T Hashizume, and K Yamashita, and K Hosoe, and T Hidaka, and K Watanabe, and H Kawaharada, and S Kudoh
February 1984, Biochemistry,
T Yamane, and T Hashizume, and K Yamashita, and K Hosoe, and T Hidaka, and K Watanabe, and H Kawaharada, and S Kudoh
April 2006, European journal of medicinal chemistry,
T Yamane, and T Hashizume, and K Yamashita, and K Hosoe, and T Hidaka, and K Watanabe, and H Kawaharada, and S Kudoh
July 2020, Bioorganic chemistry,
T Yamane, and T Hashizume, and K Yamashita, and K Hosoe, and T Hidaka, and K Watanabe, and H Kawaharada, and S Kudoh
June 2002, Archives of pharmacal research,
Copied contents to your clipboard!